Your browser doesn't support javascript.
loading
Clients in Uganda accessing preferred differentiated antiretroviral therapy models achieve higher viral suppression and are less likely to miss appointments: a cross-sectional analysis.
Nkolo, Esther K Karamagi; Ejike, Jessica Clinkscales; Sensalire, Simon; Ssali, Juliana Nabwire; Ddumba, Immaculate; Calnan, Jacqueline; Gonzalez, Carolina; Maina, Nelly; Dessie, Melaku; Bailey, Lauren; Amanyeiwe, Ugochukwu; Minior, Thomas; Srikanth, Karishma; Kadama, Herbert; Patel, Khushi; Patel, Dina.
Afiliación
  • Nkolo EKK; U.S. Agency for International Development (USAID), Kampala, Uganda.
  • Ejike JC; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
  • Sensalire S; University Research Co., LLC, USAID RHITES N-Acholi Activity Kampala, Kampala, Uganda.
  • Ssali JN; University Research Co., LLC, USAID RHITES N-Acholi Activity Kampala, Kampala, Uganda.
  • Ddumba I; U.S. Agency for International Development (USAID), Kampala, Uganda.
  • Calnan J; U.S. Agency for International Development (USAID), Kampala, Uganda.
  • Gonzalez C; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
  • Maina N; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
  • Dessie M; U.S. Agency for International Development (USAID), Office of HIV/AIDS, Prevention Care and Treatment Division, Washington, DC, USA.
  • Bailey L; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
  • Amanyeiwe U; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
  • Minior T; U.S. Agency for International Development (USAID), Office of HIV/AIDS, Prevention Care and Treatment Division, Washington, DC, USA.
  • Srikanth K; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
  • Kadama H; Ministry of Health, AIDS Control Program, Kampala, Uganda.
  • Patel K; Brown University [USAID Intern], Providence, Rhode Island, USA.
  • Patel D; GHTASC, Credence Management Solutions LLC, supporting the United States Agency for International Development (USAID), Office of HIV/AIDS, Washington, DC, United States.
J Int AIDS Soc ; 26 Suppl 1: e26122, 2023 07.
Article en En | MEDLINE | ID: mdl-37408483
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Int AIDS Soc Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article País de afiliación: Uganda Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: J Int AIDS Soc Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2023 Tipo del documento: Article País de afiliación: Uganda Pais de publicación: Suiza